137 related articles for article (PubMed ID: 38766988)
1. Experience using 675 nm laser on three cases of Fitzpatrick skin type IV-V with melasma.
Pamela RD; Vitale MD; Fusco I; Zingoni T; Yi KH
Skin Res Technol; 2024 May; 30(5):e13748. PubMed ID: 38766988
[No Abstract] [Full Text] [Related]
2. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
3. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
Zhou X; Gold MH; Lu Z; Li Y
Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
[TBL] [Abstract][Full Text] [Related]
5. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
6. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
Polnikorn N
J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
[TBL] [Abstract][Full Text] [Related]
9. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
10. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
11. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
12. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
Yue B; Yang Q; Xu J; Lu Z
Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
[TBL] [Abstract][Full Text] [Related]
14. A study of efficacy and safety of high-intensity focused ultrasound for the treatment of melasma in Asians: A single-blinded, randomized, split-face, pilot study.
Vachiramon V; Iamsumang W; Chanasumon N; Thadanipon K; Triyangkulsri K
J Cosmet Dermatol; 2020 Feb; 19(2):375-381. PubMed ID: 31173464
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
16. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
Garg S; Vashisht KR; Makadia S
J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
[No Abstract] [Full Text] [Related]
18. Senescent fibroblasts in melasma pathophysiology.
Kim M; Kim SM; Kwon S; Park TJ; Kang HY
Exp Dermatol; 2019 Jun; 28(6):719-722. PubMed ID: 30575141
[TBL] [Abstract][Full Text] [Related]
19. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.
Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R
Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085
[TBL] [Abstract][Full Text] [Related]
20. The Management of Melasma on Skin Types V and VI Using Light Emitting Diode Treatment.
Mpofana N; Abrahamse H
Photomed Laser Surg; 2018 Oct; 36(10):522-529. PubMed ID: 30227084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]